Loading clinical trials...
Loading clinical trials...
The rationale for the current protocol is to collect data from extended follow up in subjects that have received a kidney transplant following imlifidase dosing to provide a better understanding regar...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hansa Biopharma AB
NCT05325008 · BK Viremia, Kidney Transplant Infection, and more
NCT05525507 · End Stage Kidney Disease, Immunological Tolerance, and more
NCT05806749 · End Stage Kidney Disease, Immunological Tolerance, and more
NCT03380962 · Kidney Failure, Chronic, End-Stage Renal Disease, and more
NCT07083830 · Kidney Transplant Failure and Rejection, Kidney Transplant; Complications
Cedars-Sinai Medical Center
Los Angeles, California
The Johns Hopkins Hospital
Baltimore, Maryland
New York University School of Medicine
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions